Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Monitored issues related to drug pricing; issues related to gene editing and gene therapy; issues related to value based arrangements; issues related to the Patient Affordability, Value and Efficacy Act (PAVE) Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation; monitored issues related to H.R. 1839, Medicaid Services Investment and Accountability Act of 2019. Monitored issues related to the conference report accompanying H.J. Res 31.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER EMILY PORTER STACEY HUGHES KATHERINE RAAB STACEY HUGHES EMILY PORTER KATHERINE RAAB